New treatment options and technology in dermatology

Several articles in this issue update us on new treatments and technologies that have been developed to treat or assess dermatological conditions

Targeted treatment of metastatic melanoma is a rapidly advancing field, with huge advances made in recent years. In the Expert Opinion, Dr Louise Fearfield provides a roundup of the latest approved drug therapies, which have a significant impact on patient survival.

Primary hyperhidrosis is a common disorder, but one that can profoundly affect the patient's quality of life. In the Therapeutic Forum, Dr Zainab Laftah and Dr Rachael Morris-Jones outline the management options for this condition, which include the use of MiraDry, a new non-surgical treatment modality, that uses microwave technology to irreversibly destroy sweat glands.

Here, Dr Paul Charlson describes some alternative uses for botulinum toxin in facial rejuvenation, while here, Professor Richard White explores the possibilities of microneedling, a promising technique which may be used to treat scarring, to effect facial rejuvenation and potentially to administer drugs.

The Inside Edge (page 43) describes a new app that can be used to diagnose skin lesions, a sun-protective agent that has the potential to be administered systemically and a scanner that might be used to assess pressure ulcers.

Elsewhere in this issue, the Clinical Review by Dr Nuria Martinez-Alier and Dr Kirsty Le Doare outlines the diagnosis and management of chickenpox, while here, Dr Nigel Stollery considers the diagnosis of actinic keratoses. Here, Elizabeth Allen describes the work of the British Association of Skin Camouflage. In our case reports, Dr Anshoo Sahota discusses a patient with rosacea. Dr Brian Malcolm's pictorial case studies examine the dermatology of GI disease.

Don't forget this issue provides a suggested five credits of CPD for your portfolio. The 'CPD impact' boxes at the end of the articles provide suggestions for ways in which you can further increase your learning and earn more credits.

Please email any suggestions you have for MIMS Dermatology. You can contact us at

  • Sonia Davies, Clinical commissioning editor, MIMS Dermatology

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Vitamin D3 Supplements

Formulations and indications of colecalciferol preparations.

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Treatment with febuxostat (Adenuric) should be avoided...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Colestid Orange. Use our constantly updated...

Updated bowel disease treatment summaries published by MIMS

Updated bowel disease treatment summaries published by MIMS

Updated quick-reference summaries of the latest NICE...